Back
Syndax Pharmaceuticals, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
59
SNDX
Syndax Pharmaceuticals, Inc.
Last Price:
$21.01
Seasonality Move:
7.51%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atSyndax Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Syndax Pharmaceuticals, Inc. has on average historically risen by 26.1% based on the past 9 years of stock performance.
-
Syndax Pharmaceuticals, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Syndax Pharmaceuticals, Inc. Stock Undervalued?The current Syndax Pharmaceuticals, Inc. [SNDX] share price is $21.00. The Score for SNDX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
SNDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Syndax Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Syndax Pharmaceuticals, Inc. has on average historically risen by 26.1% based on the past 9 years of stock performance.
Syndax Pharmaceuticals, Inc. Stock Rating
Buy
59
Syndax Pharmaceuticals, Inc. (SNDX)
is a Buy
Is Syndax Pharmaceuticals, Inc. overpriced?
-
Syndax Pharmaceuticals, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Syndax Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
syndax.com
52-Week Data
52-Week High:
22.73
52-Week Low:
8.58
Prediction Charts
Market Cap:
1.8B
Price in USD:
21.00
Volume:
1M
Beta:
1.12
Technical Analysis
SMA50:
18.78
SMA100:
17.14
SMA200:
14.08
52-Wk Change:
52.06%
Stock Predictions
-
Is Syndax Pharmaceuticals, Inc. stock public?Yes, Syndax Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Syndax Pharmaceuticals, Inc. stock quote today?The Syndax Pharmaceuticals, Inc. stock price is 21.00 USD today.
-
How to buy Syndax Pharmaceuticals, Inc. stock online?You can buy Syndax Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-19 | 20.23 | 20.77 | 21.18 | 20.23 |
| Dec-22 | 20.52 | 21.48 | 21.50 | 20.28 |
| Dec-23 | 21.47 | 21.70 | 22.73 | 21.46 |
| Dec-24 | 21.66 | 21.60 | 21.76 | 21.34 |
| Dec-26 | 21.73 | 21.30 | 21.73 | 21.07 |
| Dec-29 | 21.12 | 21.07 | 21.41 | 20.87 |
| Dec-30 | 20.91 | 20.74 | 21.11 | 20.42 |
| Dec-31 | 20.82 | 21.01 | 21.37 | 20.62 |
| Jan-2 | 21.08 | 21.30 | 21.34 | 20.81 |
| Jan-5 | 21.35 | 20.22 | 21.54 | 19.61 |
| Jan-6 | 20.00 | 20.34 | 20.59 | 19.77 |
| Jan-7 | 20.38 | 22.11 | 22.41 | 20.38 |
| Jan-8 | 21.85 | 21.39 | 21.95 | 20.98 |
| Jan-9 | 21.38 | 21.00 | 21.60 | 20.91 |
Syndax Pharmaceuticals, Inc. Earnings
Syndax Pharmaceuticals, Inc. Earnings Report: Per Share Syndax Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Syndax Pharmaceuticals, Inc. Forecast Revenue Growth
Syndax Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Syndax Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $1.69 per share.
* Syndax Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.